• "genOway is the Mercedes Benz of transgenic outsourcing companies."

    > read full testimonial

    Prof. Robert TERKELTAUB

    Director at UC San Diego School of Medicine

  • "We have worked with genOway in different projects for several years, and we are very impressed by their competence,..."

    > read full testimonial

    Prof. Maria T. DIAZ-MECO

    Lab Head at Sanford Burnham Prebys Medical Discovery Institute

  • "I am truly impressed with the responsiveness and help that I have obtained from genOway. It has been a pleasure to work..."

    > read full testimonial

    Prof. Bellur S. PRABHAKAR

    Associate Dean at University of Illinois College of Medicine

  • "We were highly impressed by the expert manner in which genOway’s scientists managed what I felt to be a rather..."

    > read full testimonial

    Prof. Simon C. ROBSON

    Director at Beth Israel Deaconess Medical Center

  • "genOway has carried out several projects for us. This collaboration has been very successful. Not just because we have..."

    > read full testimonial

    Prof. Arne KLUNGLAND

    Lab Head at Oslo University Hospital

  • "I ascertain that genOway has provided extremely efficient and competent services to us and we will very likely use them..."

    > read full testimonial

    Prof. Ludwig NEYSES

    Chair of Medicine at University of Manchester

  • "genOway has already supplied us with several difficult-to-make knockout cell lines. We are impressed by the speed and..."

    > read full testimonial

    Prof. Hans CLEVERS

    Director Research of Princess Maxima Center

  • "genOway provides us with a very professional services within the expected timelines and high quality scientific..."

    > read full testimonial

    Prof. Gerd WALZ

    Director at Albert Ludwigs University Freiburg

  • "Without you it would have been impossible for us to establish this transgenic mouse from the EUCOMM ES cells. I was most..."

    > read full testimonial

    Dr. Matthias HUNDT

    Instructor at La Jolla Institute for Allergy & Immunology

  • "For more than two years we have worked with the scientific staff at genOway appreciating their fruitful and constant..."

    > read full testimonial

    Prof. Gianfranco SEBASTIO

    University of Naples Federico II

  • "genOway's technology is excellent and their mouse business is impressive. We are looking forward to working..."

    > read full testimonial

    Dr. Ulrich THIBAUT

    Supervisory Board of Glycotope GmbH Berlin

  • "genOway has not only successful provided this service, but we have benefited a great deal from their consultation,..."

    > read full testimonial

    Dr. Paul RILEY

    Chair of Development and Cell Biology at Oxford University

  • "genOway is a very reliable company. They provide a very flexible service customized to our needs and expectation. I..."

    > read full testimonial

    Dr. Angela GRECO

    Director at IRCCS Foundation Milan

  • "genOway has really impressed me with the quality of its service and its competence. I would emphasize their reliability..."

    > read full testimonial

    Prof. Ruben PIO

    Director at CIMA, University of Navarra

  • "With the idea to develop a mouse model for the rare human disease ALD, we reached out to genOway to help us in finding..."

    > read full testimonial

    Dr. Stephan KEMP

    Associate Professor at Academic Medical Center (AMC)

  • "We are actively engaged in the production of a number of knock-in mouse models with genOway. We have been very pleased..."

    > read full testimonial

    Prof. Stephen MOSS

    Chair of Biomedical Research at University College London

  • "genOway is a leading company in the field of genetically modified mouse and rat models. Its technology platform is..."

    > read full testimonial

    Prof. Pier Paolo DI FIORE

    IFOM-IEO Campus, University of Milan

  • "It goes without saying that knockout technologies are an indispensible research tool in Hepatology. In this regard we..."

    > read full testimonial

    Prof. Dr. Dieter HÄUSSINGER

    Director at Heinrich Heine University Düsseldorf

  • "I have never witnessed such proactive behavior with customers. genOway truly understand our challenges and is equipped..."

    > read full testimonial

    Dr. Carla BOCCACCIO

    University of Torino Medical School

  • "Mouse knock-out technology is an important step in cancer research, it provides relevant answers to scientific questions..."

    > read full testimonial


    IFOM-IEO Campus, University of Milan


What We Stand For

What We Stand For

"Thorough project assessment, in-depth scientific analysis of your current and future needs, exhaustive technology portfolio, excellence in production, and dedicated customer care are the core pillars that distinguish our personalized genome engineering service...
We translate your project into the most adapted and physiologically relevant research model."

Alexandre Fraichard
General Manager - genOway

At a Glance

At a Glance

genOway has created more than 1500 genetically modified models, while serving clients in:

• 28 countries worldwide,
• 265 academic institutions and 13 EU projects,
• 70 biopharmaceutical, and
• 14 of the Top 20 pharma companies

Cell Models (Customized)

Genetically engineering of cell lines, primary and pluripotent stem cells (e.g. iPS cells).

> Read more Cell Models (Customized)

Mouse Models (Customized)

Fully adapted to your needs, ranging from basic research to preclinical studies.

> Read more Mouse Models  (Customized)

Rat Models (Customized)

Generation of Knockout and point mutation rat models on a large choice of genetic backgrounds.

> Read more Rat Models (Customized)

Mouse Lines (Catalog)

Access to the largest repository of Knockout and reporter mouse models.

> Find your model Mouse Lines (Catalog)


Molecular validation of your model (gene expression, RNA stability, alternative splicing, etc.)

> Read more Phenotyping

Free Consulting

Contact our scientific consultants for a free project assessment and scientific analysis.

> Contact us Free Consulting

Latest Clients Publications

  • Liu Q et al.

    Front Cell Neurosci. 2017 Sep 22

    | Distinctive Roles for α7*- and α9*-Nicotinic...

  • Morley BJ et al.

    Front Neurosci. 2017 Sep 21

    | Generation and Characterization of α9 and α10...

  • Lee SM et al.

    J Steroid Biochem Mol Biol. 2017...

    | The impact of VDR expression and regulation in...

  • Hu LR et al.

    Sci Adv. 2017 Jun 7

    | Deregulated Ca2+ cycling underlies the development...

  • Becker LA et al.

    Nature. 2017 Apr 20

    | Therapeutic reduction of ataxin-2 extends lifespan...